BCM
BCEL

Bayesian Capital Management’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bayesian Capital Management’s Portfolio BCEL Stock Details BCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,600
Closed -$34K – 1162
2022
Q1 		$34K Buy
+10,600
New +$25.7K 0.01% 742

Other funds holding BCEL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bayesian Capital Management's BCEL Position: Q2 2022 in Review

Bayesian Capital Management sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q2 2022, closing a stake of 10,600 shares — an estimated $34K sold.

Bayesian Capital Management first reported a position in BCEL in Q1 2022 and held it in 1 quarter. The position peaked at $34K in Q1 2022. 80 funds tracked by Wall St. Rank hold BCEL as of Q2 2022.

  • Bayesian Capital Management reported no remaining Atreca, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 10,600 Atreca, Inc. Class A Common Stock shares in Q2 2022, an estimated $34K.
  • Bayesian Capital Management first reported a position in Atreca, Inc. Class A Common Stock in Q1 2022 and held it in 1 quarter.
  • Bayesian Capital Management's Atreca, Inc. Class A Common Stock position peaked at $34K in Q1 2022.
  • 80 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.